no statement of use filed
on 28 Jun 2021
Last Applicant/ Owned by
6-8, Doshomachi 2-chome, Chuo-ku
Osaka-shi, Osaka
JP
-
Serial Number
87471459 filed on 01st Jun 2017
Registration Number
N/A
Correspondent Address
Rebeccah Gan
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of the stylized letter "C" in purple. Two curved ray designs begin under the letter "C", and curve up and terminate at the bottom of the letter "C", then continue above the letter "C", and curve up and to the right. The top of the two rays is yellow, and the bottom ray is gray. There is a custom star design in purple and yellow in the middle of the letter "C". All of which is setRead More
Providing medical information
Pharmaceutical preparations for the treatment of cancer
No 87471459
No Service Mark
No TM17-6279
No
No
No
No
No
No
No
No
01.01.04 -
A single star with six points
01.15.25 -
Other natural phenomena and observable events
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the stylized letter "C" in purple. Two curved ray designs begin under the letter "C", and curve up and terminate at the bottom of the letter "C", then continue above the letter "C", and curve up and to the right. The top of the two rays is yellow, and the bottom ray is gray. There is a custom star design in purple and yellow in the middle of the letter "C". All of which is set against a white background which is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 28th Jun 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 28th Jun 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 06th Oct 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 05th Oct 2020 | EXTENSION 5 GRANTED |
| 05th Oct 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 30th Sep 2020 | EXTENSION 5 FILED |
| 30th Sep 2020 | TEAS EXTENSION RECEIVED |
| 01st Apr 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Mar 2020 | EXTENSION 4 FILED |
| 30th Mar 2020 | TEAS EXTENSION RECEIVED |
